The Competition Commission of India (CCI) has approved the acquisition of 100% equity shares of Medlife International Private Limited (“Medlife”) by API Holdings Private Limited (“API Holdings”). It also approved the acquisition of up to 19.59% equity share capital of API Holdings by Medlife’s shareholders under Section 31(1) of the Competition Act, 2002.
API is a private company, incorporated in 2019. API directly or through its subsidiaries carries out various business activities including wholesale sale and distribution of drugs; transportation and delivery services primarily focused on pharmaceutical sector; owning technology and intellectual property for developing e- commerce platforms. Medlife is primarily a healthcare company engaged in the wholesale sale and distribution of drugs.
Important takeaways for all competitive exams:
In a major diplomatic breakthrough, India and Pakistan have agreed to a full and immediate…
This Mother’s Day, ask yourself: “What’s the most meaningful gift you’ve ever given to your…
Mother’s Day is a heartfelt tribute to the unwavering love, resilience, and dedication of mothers…
The three flagship social security schemes under the Jan Suraksha Abhiyan — Pradhan Mantri Jeevan…
In a strong regulatory move, the Reserve Bank of India (RBI) has imposed monetary penalties…
On May 9, 2025, Uttar Pradesh Chief Minister Yogi Adityanath, in the presence of World…
![](data:image/svg+xml;charset=utf-8,<svg height="167px" width="300px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="34px" width="156px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
